Wei Long1, Dan Liang2, Yihua Tan1, Mingfu Pan1, Yuandai Luo1,*
1International Zhuang Medicine Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning 530200, Guangxi, China.
2Graduate School of Guangxi University of Chinese Medicine, Nanning 530200, Guangxi, China.
*Corresponding author: Yuandai Luo
Guangxi TCM Appropriate Technology Development and Promotion Project 2024 (Project No. gxsy 2024050); Three-Year Action Plan Project for the Construction of High-Level Talent Teams in Guangxi International Zhuang Medicine Hospital, 2023 (gzcx20231201): Innovative Team for Prevention and Treatment of Longlu Disease with Zhuang Medicine and Pharmacology.
References
[1] Ni H, Ge Y, Zhuge Y, et al. LncRNA MIR181A1HG deficiency attenuates vascular inflammation and atherosclerosis. Circ Res. 2025.
[2] Chong B, Jayabaskaran J, Jauhari MS, et al. Global burden of cardiovascular diseases: projections from 2025 to 2050. Eur J Prev Cardiol. 2024.
[3] Wu J, Bai X, Yan L, et al. Selective regulation of macrophage lipid metabolism via nanomaterials’ surface chemistry. Nat Commun. 2024;15:8349.
[4] Sun Y, Wang YW, Liu JY, et al. Analysis of the anticoagulant activity substances of leech and research progress on extraction and purification of hirudin. Acta Neuropharmacol. 2021;11(05):30-33.
[5] Liang GW, Jiang MH. Experimental study on the protective effect of hirudin on arterial endothelium. Tianjin Med J. 2012;40(12):1234-1236.
[6] Retraction: Hirudin ameliorates immunoglobulin A nephropathy (IgA nephropathy, also known as Berger’s disease) by inhibition of fibrosis and inflammatory response. Ren Fail. 2025;47(1):2462380.
[7] Weidong W, Feng Z, CW L, et al. The value of postconditioning in plastic and reconstructive surgery: a systematic review. J Reconstr Microsurg. 2016;32(4):285-93.
[8] Yang QH, Zhang JX, Zhou ZH. Construction of hirudin-oxalic acid vitamin E ester liposomes and in vitro evaluation of their anticoagulant activity. J Army Med Univ. 2024;46(21):2475-2484.
[9] Wang JJ, Wang WH. Study on the effect of hirudin on coagulation function and endothelial function in hypertensive patients. J New Chin Med. 2019;51(05):123-125.
[10] Ajoolabady A, Pratico D, Lin L, et al. Inflammation in atherosclerosis: pathophysiology and mechanisms. Cell Death Dis. 2024;15(11):817.
[11] Ramoni D, Carbone F, Kraler S, et al. Inflammation-driven plaque erosion in atherosclerosis: a focus on complement system pathways. Curr Atheroscler Rep. 2025;27(1):42.
[12] Jhoseline DM, Oscar Z, Mayra D, et al. Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches. Int J Mol Sci. 2021;22(8):3850.
[13] Laura HA, Julián JA, Fog JB. Mechanisms of fibrous cap formation in atherosclerosis. Front Cardiovasc Med. 2023;10:1254114.
[14] Melania G, Francesca G, Cristina V. Lipids in atherosclerosis: pathophysiology and the role of calculated lipid indices in assessing cardiovascular risk in patients with hyperlipidemia. Int J Mol Sci. 2022;24(1):75.
[15] Parto B, Maryam M, Sepideh B, et al. The relation between atherosclerosis plaque composition and plaque rupture. J Med Signals Sens. 2020;10(4):267-273.
How to cite this paper
Research Progress on the Effects and Mechanisms of Hirudin on the Stability of Atherosclerotic Plaques
How to cite this paper: Wei Long, Dan Liang, Yihua Tan, Mingfu Pan, Yuandai Luo. (2025) Research Progress on the Effects and Mechanisms of Hirudin on the Stability of Atherosclerotic Plaques. International Journal of Clinical and Experimental Medicine Research, 9(6), 692-697.
DOI: http://dx.doi.org/10.26855/ijcemr.2025.11.021